ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,187.67
0.00%
US Tech 100
17,585.60
-0.15%
다우존스 지수
39,056.39
0.44%
Bitcoin
61,516.53
0.54%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 이탈리아
  5. BIT
  6. Sanofi (1SAN)

  7. Sanofi (1SAN) 뉴스

1SAN Sanofi

93.18
1.49 (1.63%)
09 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Sanofi 1SAN 이탈리아 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
1.49 1.63% 93.18 00:30:08
개장가 저가 고가 종가 전일 종가
92.92 92.75 93.55 93.18 91.69
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202414:00GLOBECommuniqué de presse : Des données de vie réelle concernant..
01/05/202401:00GLOBECommuniqué de presse : Assemblée Générale Annuelle du 30..
25/04/202414:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
23/04/202414:00GLOBECommuniqué de presse : L’étude de phase III LUNA 3 du..
17/04/202414:00GLOBEPress Release: New 48-week frexalimab phase 2 data support..
13/04/202403:05GLOBESanofi: Information concerning the total number of voting..
09/04/202401:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/03/202415:30GLOBECommuniqué de presse : Mise en ligne du document «Q1 2024..
16/03/202404:04GLOBESanofi: Information concerning the total number of voting..
11/03/202415:00GLOBEPress Release: New Phase 2b results for amlitelimab support..
24/02/202423:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
24/02/202402:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
23/02/202415:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
23/02/202403:02GLOBEPress Release: Sanofi’s Board of Directors proposes the..
21/02/202407:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/02/202415:00GLOBEPress Release: Japan first in the world to approve Dupixent®..
15/02/202422:00GLOBEPress Release: Phase 2 data published in NEJM show potential..
05/02/202416:00GLOBEPress Release: Peer support, flexible work arrangements,..
01/02/202415:30GLOBECommunique de presse - 2023 : Croissance des ventes et du..
26/01/202404:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
23/01/202415:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
18/01/202406:57GLOBESanofi: Informations relatives au nombre de droits de vote..
09/01/202415:30GLOBEPress Release: Brian Foard appointed Head of Specialty Care..
21/12/202315:30GLOBEPress Release: Sanofi announces end of program evaluating..
19/12/202305:59GLOBESanofi: Informations relatives au nombre de droits de vote..
15/12/202315:30GLOBECommuniqué de presse : Mise en ligne du document «Q4 2023..
15/12/202315:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
12/12/202306:08GLOBEPress Release: Statement on FTC challenge to proposed..
11/12/202309:30GLOBEPress Release: Sarclisa® (isatuximab) plus KRd significantly..
07/12/202315:35GLOBEPress Release: Sarclisa® (isatuximab) Phase 3 trial met..
07/12/202311:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
27/11/202315:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
24/11/202302:00GLOBESanofi: Information concerning the total number of voting..
27/10/202314:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
27/10/202314:30GLOBEPress Release: Sanofi Enters Next Chapter of Play to Win..
23/10/202304:00GLOBECommuniqué de presse : Des résultats de phase III relatifs à..
19/10/202319:00GLOBEPress Release: Sanofi delivers first medicines from Global..
18/10/202317:45GLOBECommuniqué de presse : Des données de ph III présentées au..
18/10/202303:18GLOBESanofi: Informations relatives au nombre de droits de vote..
13/10/202323:00GLOBEPress Release: Late-breaking amlitelimab Phase 2b data..
04/10/202314:00GLOBEPress Release: Sanofi and Teva announce exclusive..
03/10/202314:30GLOBECommuniqué de presse : Sanofi annonce un accord sur un..
26/09/202314:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
25/09/202316:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
22/09/202314:30GLOBECommuniqué de presse : Mise en ligne du document « Q3 2023..
19/09/202315:30GLOBEPress Release: Sanofi supporting vulnerable communities as..
12/09/202303:02GLOBESanofi: Informations relatives au nombre de droits de vote..
31/08/202314:30GLOBECommuniqué de presse: Sanofi annonce des changements au sein..
16/08/202304:24GLOBESanofi: Informations relatives au nombre de droits de vote..
04/08/202304:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..

최근 히스토리

BIT
1SAN
Sanofi
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유